Women face lower diagnostic risks and proper management of CKD – ​​Consumer Health News

TUESDAY, August 9, 2022 (HealthDay News) — According to a study published online July 29 in the Journal of the American Society of Nephrology.

Oskar Swartling, MD, of Karolinska Institutet in Stockholm, and colleagues assessed gender differences in CKD using data from 227,847 adults with probable CKD (at least one outpatient estimated flow glomerular filtration rate 2 measure from 2009 to 2017).

Researchers found that women were less likely to have received a diagnosis code for CKD and were less likely to have received a renin-angiotensin system inhibitor and statins, despite having indications recommended by guiding lines. Regardless of disease severity, presence of albuminuria, or referral criteria, women were less likely to have been diagnosed with CKD (relative risk, 0.43) and seen a nephrologist (relative risk, 0.46). Even among women with diabetes or hypertension, women were also less likely to have creatinine or albuminuria monitored. When adjusting for comorbidities, albuminuria, and highest level of education and among those with confirmed CKD on retest, sex-related associations persisted. Despite improvements in nephrology care indicators over time, the observed gender gap persisted.

“Efforts to improve and ensure gender-equitable health care could have important implications for justice and could reduce the burden of chronic kidney disease,” the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Summary/Full text

Comments are closed.